1. "Genitourinary Oncology Service"
Formats
  1. Journal Article (2745)
  2. Meeting Abstract (2507)
  3. Review (113)
  4. Book Section (82)
  5. Editorial (52)
  6. Correspondence (33)
  7. Conference Paper (29)
  8. Guidelines (24)
  9. Research Letter (15)
  10. Book Whole (4)
  11. Miscellaneous (4)
Groups
  1. Genitourinary Oncology Service (5608)
  2. Solid Tumor Oncology Division (5608)
  3. Department of Medicine (5598)
  4. GSK Faculty (1640)
  5. Human Oncology and Pathogenesis Program (1139)
  6. Department of Pathology and Laboratory Medicine (1034)

More Groups

People
  1. Robert Motzer (1243)
  2. Howard Scher (1130)
  3. David Solit (779)
  4. Dean Bajorin (657)
  5. Michael Morris (577)
  6. Jonathan Rosenberg (510)

More People

Years
  1. 2025 (118)
  2. 2024 (293)
  3. 2023 (283)
  4. 2022 (314)
  5. 2021 (341)
  6. 2020 (352)

More Years

Publications
  1. Journal of Clinical Oncology (1697)
  2. Annals of Oncology (303)
  3. Clinical Cancer Research (282)
  4. Cancer Research (245)
  5. Cancer (125)
  6. European Urology (118)

More Publications

Publishers
  1. American Society of Clinical Oncology (1757)
  2. American Association for Cancer Research (688)
  3. Oxford University Press (408)
  4. Elsevier Science, Inc. (389)
  5. Elsevier Inc. (384)
  6. Nature Publishing Group (294)

More Publishers

Results (5608)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Genomic characterization of metastatic urothelial carcinoma
    Meeting Abstract

    Bambury, R. M.; Riester, M.; Bellmunt, J.; Stack, E. C.; Werner, L.; Park, R.; Iyer, G.; Loda, M.; Kantoff, P. W.; Michor, F.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Quality of life (QoL) among patients with renal cell carcinoma (RCC) treated with pazopanib versus sunitinib in the COMPARZ study
    Meeting Abstract

    Cella, D.; Hackshaw, M. D.; Diaz, J.; Huang, C.; Deen, K. C.; Crescenzo, R.; Motzer, R. J.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Treatment benefit of tivozanib hydrochloride versus sorafenib on health-related quality of life (HRQoL) among patients (pts) with advanced/metastatic renal cell carcinoma (mRCC): TIVO-1 study results
    Meeting Abstract

    Cella, D.; Ivanescu, C.; Skaltsa, K.; Casamayor, M.; Strahs, A. L.; Esteves, B.; Berkenblit, A.; Motzer, R. J.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • A phase II multicenter study of neoadjuvant dose-dense methotrexate, vinblastine, doxorubicin, and cisplatin (ddMVAC) chemotherapy with pegfilgrastim support in patients (pts) muscle-invasive urothelial cancer (MIUC): Safety, pathologic, radiologic, and molecular correlates
    Meeting Abstract

    Choueiri, T. K.; Jacobus, S. J.; Qu, A. Q.; Sweeney, C.; Appleman, L. J.; Tretter, C. P. G.; Bubley, G. J.; Elfiky, A.; Park, R.; Stack, E. C.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Prostate-specific mRNA detection in whole blood as an analytically validated prognostic biomarker for patients with castration-resistant prostate cancer (CRPC)
    Meeting Abstract

    Danila, D. C.; Anand, A.; Heller, G.; Wan, M.; Herkal, A.; Patel, C.; Khanin, R.; Schultz, N.; Lilja, H.; Fleisher, M.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Antitumor activity of brentuximab vedotin in CD30 positive refractory germ cell tumors
    Meeting Abstract

    Albany, C.; Feldman, D. R.; Garbo, L. E.; Einhorn, L. H.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • A comparison of toxicity of gemcitabine versus platinum-based combined chemoradiation for muscle-invasive bladder cancer: The Memorial Sloan-Kettering experience
    Meeting Abstract

    Baliga, S.; Pei, X.; Bajorin, D. F.; Rosenberg, J. E.; Bochner, B.; Kollmeier, M.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Risk assessment for severe hypocalcemia requiring hospitalization with denosumab
    Meeting Abstract

    Autio, K. A.; Farooki, A.; Glezerman, I.; Chan, A.; Barr, H. C.; Seyboth, B. M.; Schneider, C. W.; Heller, G.; Scher, H. I.; Morris, M. J.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Exome sequencing of extreme phenotypes to identify variants predictive of response to chemotherapy in bladder cancer
    Meeting Abstract

    Alanee, S.; Shah, S.; Stratton, K. L.; Garcia-Grossman, I. R.; Zabor, E.; Ostrovnaya, I.; Joseph, V.; Pendse, D.; Bajorin, D. F.; Offit, K.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Overall survival (OS) and safety of dasatinib/docetaxel versus docetaxel in patients with metastatic castration-resistant prostate cancer (mCRPC): Results from the randomized phase III READY trial
    Meeting Abstract

    Araujo, J. C.; Trudel, G. C.; Saad, F.; Armstrong, A. J.; Yu, E. Y.; Bellmunt, J.; Wilding, G.; McCaffrey, J.; Serrano, S. V.; Matveev, V.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save